|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date / Period | Status |
|---|---|---|
| Polyp of colon | 06-Jun-2025 | active |
| Chronic kidney disease stage 2 | 29-Jun-2018 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 29-Jun-2018 | active |
| Disorder of kidney due to diabetes mellitus | 02-Dec-2016 | active |
| Chronic kidney disease stage 1 | 02-Dec-2016 | active |
| Obstructive sleep apnea syndrome | 08-Jun-2010 | active |
| Sleep disorder | 28-May-2010 | active |
| Substance dependence | 13-Sep-2006 | active |
| Recurrent urinary tract infection | 07-Jan-2002 | active |
| Essential hypertension | 05-Aug-1994 | active |
| Chronic intractable migraine without aura | 28-Oct-1991 | active |
| Impacted molars | 13-Aug-1990 | active |
| Overdose | 07-May-2024 - 08-May-2024 | inactive |
| Overdose | 12-Dec-2023 - 12-Dec-2023 | inactive |
| Eclampsia in pregnancy | 07-Apr-2023 - 21-Apr-2023 | inactive |
| Pre-eclampsia | 13-Aug-2021 - 24-Sep-2021 | inactive |
| Overdose | 28-Feb-2020 - 28-Feb-2020 | inactive |
| Viral sinusitis | 19-Jul-2019 - 29-Jul-2019 | inactive |
| Overdose | 13-Nov-2018 - 13-Nov-2018 | inactive |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2025-07-18 | - | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
| Hydrochlorothiazide 25 mg oral tablet | 2025-07-18 | - | 1 tablet (25 mg) by mouth once daily | Essential hypertension (disorder) |
| Lisinopril 10 mg oral tablet | 2025-07-18 | - | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
Immunizations list
| Vaccine | Date |
|---|---|
| Live attenuated Human alphaherpesvirus 3 only vaccine product | 18-Jul-2025 |
| Influenza virus antigen only vaccine product | 20-Dec-2024 |
| SARS-CoV-2 mRNA vaccine | 23-Apr-2021 |
| Hepatitis A virus antigen only vaccine product | 02-Dec-2016 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 02-Dec-2016 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Episiotomy | 10-Jan-2025 | Normal pregnancy (finding) |
| Sleep apnea assessment | 28-Jun-2024 | Sleep disorder (disorder) |
| Assessment of health and social care needs | 28-Jun-2024 | - |
| Assessment of anxiety | 28-Jun-2024 | - |
| Medication reconciliation | 26-Jan-2024 | - |
| Epidural anesthesia | 21-Apr-2023 | Normal pregnancy (finding) |
| Medical induction of labor | 24-Sep-2021 | Normal pregnancy (finding) |
| Depression screening | 16-Oct-2020 | - |
| Screening for domestic abuse | 26-Jul-2019 | - |
| Depression screening using PHQ-9 (Patient Health Questionnaire 9) score | 26-Oct-2018 | - |
Allergies and Intolerances
| No known allergies or intolerances |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Care plan | 15-Dec-2007 | Obstructive sleep apnea syndrome (disorder) |
|
||
| Lifestyle education regarding hypertension | 05-Aug-1994 | Essential hypertension (disorder) |
|
Vital Signs
| Vital Signs | 2025-07-18 | 2025-05-23 |
|---|---|---|
| Body Height | 158.5 cm | 158.5 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 1 {score} | 4 {score} |
| Body Weight | 99.3 kg | 99 kg |
| Body mass index (BMI) [Ratio] | 39.5 kg/m2 | 39.4 kg/m2 |
| Heart rate | 63 /min | 90 /min |
| Respiratory rate | 16 /min | 13 /min |
| Blood pressure panel with all children optional | 66 mm[Hg] | 63 mm[Hg] |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 18-JUL-2025 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Serum or Plasma | 94.5 | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Serum or Plasma | 7.3 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Serum or Plasma | 2.0 H | 0.5 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Serum or Plasma | 8.9 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Serum or Plasma | 136.0 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Serum or Plasma | 5.0 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Serum or Plasma | 102.1 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 20.2 L | 22 - 29 | mmol/L |
| Appearance of Urine | Cloudy urine | ||
| Odor of Urine | Urine smell ammoniacal | ||
| Clarity of Urine | Translucent | ||
| Color of Urine | Brown color | ||
| Glucose [Mass/volume] in Urine by Test strip | 2.4 | 0 - 5 | mg/dL |
| Glucose [Presence] in Urine by Test strip | Urine glucose test = ++ | ||
| Bilirubin.total [Mass/volume] in Urine by Test strip | 1.0 | 0 - 4 | mg/dL |
| Bilirubin.total [Presence] in Urine by Test strip | Finding of bilirubin in urine | ||
| Ketones [Mass/volume] in Urine by Test strip | 18.3 | 0 - 20 | mg/dL |
| Ketones [Presence] in Urine by Test strip | Urine ketone test = + | ||
| Specific gravity of Urine by Test strip | 1.0 L | 1.005 - 1.030 | {nominal} |
| pH of Urine by Test strip | 5.5 | 5.0 - 8.0 | pH |
| Protein [Mass/volume] in Urine by Test strip | 310.7 H | 0 - 20 | mg/dL |
| Protein [Presence] in Urine by Test strip | Urine protein test = ++ | ||
| Nitrite [Presence] in Urine by Test strip | Urine nitrite negative | ||
| Hemoglobin [Presence] in Urine by Test strip | Urine blood test = negative | ||
| Leukocyte esterase [Presence] in Urine by Test strip | Urine leukocyte test negative |
Device Use
| Device | Date (since) |
|---|---|
| Home continuous positive airway pressure unit (physical object) | 21-Mar-2025 |
| Respiratory humidifier (physical object) | 21-Mar-2025 |